Study of Telitacicept in Generalized Myasthenia Gravis

NCT05737160 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
114
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

RemeGen Co., Ltd.